» Articles » PMID: 17943448

Neuropsychological and Behavioral Effects of Antiepilepsy Drugs

Overview
Specialties Neurology
Psychology
Date 2007 Oct 19
PMID 17943448
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Antiepilepsy drugs work by decreasing neuronal irritability, which may also result in the non-desired side effect of decreased neuropsychological function. In addition to cognitive side effects, antiepilepsy drugs (AEDs) may be associated with behavioral effects which may range from irritability and hyperactivity to positive psychotropic effects on mood. There have been many new medications released since the 1990s, and although they tend to have more favorable side effect profiles compared to their older counterparts, there continues to be a risk of decreased cognitive function with the majority of these agents. The effects of in utero antiepilepsy drug exposure are increasingly being investigated, and differential drug risk is beginning to be described for both anatomic and cognitive outcomes. Patients with epilepsy undergoing neuropsychological evaluations are commonly on AEDs, and it is important for the clinician to recognize the potential contribution of AED therapy to neuropsychological profiles. The present article serves to provide an overview of our current understanding regarding the risks of antiepilepsy drug use for both cognitive and behavioral side effects.

Citing Articles

Neuropsychological morbidity in the First Seizure Clinic: Prominent mood symptoms and memory issues in epilepsy.

Pugh R, Vaughan D, Jackson G, Ponsford J, Tailby C Epilepsia Open. 2024; 10(1):258-268.

PMID: 39560466 PMC: 11803273. DOI: 10.1002/epi4.13103.


Emotional intelligence in children with epilepsy.

Enkhtuya B, Bayarsaikhan A, Lkhagvasuren B, Sainbat U, Bayanmunkh B, Avirmed T IBRO Neurosci Rep. 2024; 16:260-266.

PMID: 39007084 PMC: 11240295. DOI: 10.1016/j.ibneur.2024.01.013.


The relevance of Spearman's for epilepsy.

Struck A, Garcia-Ramos C, Nair V, Prabhakaran V, Dabbs K, Conant L Brain Commun. 2024; 6(3):fcae176.

PMID: 38883806 PMC: 11179110. DOI: 10.1093/braincomms/fcae176.


An observational time-series study on the behavioral effects of adjunctive artisanal cannabidiol use by adults with treatment resistant epilepsies.

Brett B, Conroy M, Doshi H, Lowe M, Kalcheff-Korn S, Jackson H BMC Neurol. 2024; 24(1):141.

PMID: 38671370 PMC: 11046917. DOI: 10.1186/s12883-024-03646-8.


Transient targeting of hypothalamic orexin neurons alleviates seizures in a mouse model of epilepsy.

Li H, Viskaitis P, Bracey E, Peleg-Raibstein D, Burdakov D Nat Commun. 2024; 15(1):1249.

PMID: 38341419 PMC: 10858876. DOI: 10.1038/s41467-024-45515-5.


References
1.
Kossoff E, Bergey G, Freeman J, Vining E . Levetiracetam psychosis in children with epilepsy. Epilepsia. 2002; 42(12):1611-3. DOI: 10.1046/j.1528-1157.2001.32101.x. View

2.
Rowan A, Ramsay R, Collins J, Pryor F, Boardman K, Uthman B . New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005; 64(11):1868-73. DOI: 10.1212/01.WNL.0000167384.68207.3E. View

3.
Martin R, Kuzniecky R, Ho S, Hetherington H, Pan J, Sinclair K . Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology. 1999; 52(2):321-7. DOI: 10.1212/wnl.52.2.321. View

4.
Meador K, Loring D, Hulihan J, Kamin M, Karim R . Differential cognitive and behavioral effects of topiramate and valproate. Neurology. 2003; 60(9):1483-8. DOI: 10.1212/01.wnl.0000063308.22506.19. View

5.
Smith D, Baker G, Davies G, Dewey M, Chadwick D . Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 1993; 34(2):312-22. DOI: 10.1111/j.1528-1157.1993.tb02417.x. View